Use of buprenorphine in pregnancy: patient management and effects on the neonate.
about
Maintenance agonist treatments for opiate-dependent pregnant womenMaintenance agonist treatments for opiate dependent pregnant womenOpioid dependency in pregnancy and length of stay for neonatal abstinence syndromeSublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trialPharmacologic management of the opioid neonatal abstinence syndromeOpioids in pregnancy and neonatal abstinence syndromeNeonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.Neonatal abstinence syndrome after methadone or buprenorphine exposureNeurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysisPractical considerations for the clinical use of buprenorphine.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Safety of the newer class of opioid antagonists in pregnancy.SOGC clinical practice guidelines: Substance use in pregnancy: no. 256, April 2011.Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment.Buprenorphine: a (relatively) new treatment for opioid dependence.Buprenorphine: new treatment of opioid addiction in primary care.Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.Effect of plasma proteins on buprenorphine transfer across dually perfused placental lobule.Peripartum pain management in opioid dependent womenEvaluation of the vaginal flora in pregnant women receiving opioid maintenance therapy: a matched case-control study.Birth and Neonatal Outcomes Following Opioid Use in Pregnancy: A Danish Population-Based Study.Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone.Medical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment.A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal OutcomesNeonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting.Narrative review: buprenorphine for opioid-dependent patients in office practice.Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconiumPsychopharmacologic management of opioid-dependent women during pregnancy.Prenatal drug exposure: infant and toddler outcomes.Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.Buprenorphine for the treatment of perinatal opioid dependence: pharmacology and implications for antepartum, intrapartum, and postpartum care.Buprenorphine use in pregnant opioid users: a critical review.Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.Buprenorphine--the unique opioid adjuvant in regional anesthesia.Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and GynecoPrenatally buprenorphine-exposed children: health to 3 years of age.
P2860
Q24201642-0B137B7B-93C8-4368-BB0B-CA6D5E8AB3BBQ24242986-7143535C-959B-41F2-82E9-6A268B207A3EQ24628765-FF61B443-7A57-4107-8847-EB6180B23B1FQ24647455-27AF8804-ACDF-4A76-93C2-6FED4B824DCEQ26863355-DDFC7FDB-5DAD-4DC8-8B55-2C17510AA6B8Q28082706-5E7732EE-128A-4321-AFF8-1963CEBF1D17Q30249670-914B7E38-7515-4E70-9449-865124D814A8Q30490602-C753E5A7-77A3-480D-9561-CB16C6DE1796Q30499416-3D29C7AB-1B3A-4B26-9B9F-729FEC11B675Q33612388-9801C73B-EA5F-4F61-BF07-42950A52058EQ33774853-30D30992-CEA1-4C2F-B094-A34AFFB10F41Q33870389-0F3A8D2F-CB5D-4A68-B794-8FC8A058C4BDQ33894730-BABC9AD9-86F1-4250-AB08-21AB8BFFB10EQ34003615-C5C009D0-660A-4295-BF56-B2F30D15FFC5Q34051048-59A2C864-F0B5-4333-8D2D-6EA1FF4792FAQ34365302-991FC7A6-E1AB-4A59-A3CF-C4D01B9FFD34Q34667890-2200FD04-E6B4-4807-A02E-3C0D244D8571Q34721065-E96AFF6D-2453-43E3-AC0C-6F2BEF85C7FCQ35244943-A79244D6-23FB-4508-BED2-F83B82F96989Q35548503-03C59B48-48FE-4C80-92A5-8883646A66BFQ35618710-FE3D573D-AC47-4A82-BFF4-1D5A8B4F02BFQ35791067-8B5D1E3B-D052-4E51-94DD-96F9EE5DBB64Q36096257-CCC9D13F-EAA9-4F8B-8FDE-7CE4FB923A8FQ36142245-F2CDE686-910A-4D38-9875-C0968CD7CE7AQ36165912-3AD6C2EA-5830-4AF7-AF03-10E4CCB3BB6DQ36311018-8A2EB1A9-64F0-411F-993E-59C76AF3B1A0Q36702592-AA803163-C3B6-495A-92EF-D9CB60BDD174Q36730570-559B7D99-E62A-422E-BD0D-4A8B0FF5D6D5Q36927637-788B8663-02EF-413D-A9B0-909D526F8FBBQ36959052-108963CD-749E-42F4-A14A-9FE71DFC4F3DQ37210263-F1C8831B-8D24-47F3-9261-E546D4BA80C6Q37421838-0E5F851C-D8B7-41E8-A862-C4355AC3FE1DQ37734984-0DB4C19F-BFB4-4578-B5E1-09CCE250D1A1Q37863594-F9CD935B-9E99-4EE3-9405-A7598F06BEDEQ37871042-B5C0A32A-4B23-40C3-9A8A-5BAE9144C452Q38115201-CDBF8D92-2DDB-40E0-A66C-4D78F4615057Q38127854-7786C8F9-9218-480A-B160-3A989B29A0B4Q38694075-B3558E9E-32B6-4827-828D-48CED6F06768Q39359619-D2746B9A-43AF-4759-826A-26AEF16DD261Q40908237-DC3D38BF-4D27-418D-9E0F-14DCC994B533
P2860
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
@ast
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
@en
type
label
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
@ast
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
@en
prefLabel
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
@ast
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
@en
P1476
Use of buprenorphine in pregnancy: patient management and effects on the neonate.
@en
P2093
Gabriele Fischer
Rolley E Johnson
P304
P356
10.1016/S0376-8716(03)00062-0
P433
P577
2003-05-01T00:00:00Z